Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ambrilia Biopharma reports positive results from Phase III acromegaly study
In addition, the efficacy as measured by the mean insulin-like growth factor 1 (IGF-1) and growth hormone (GH) plasma levels is maintained at the same level throughout the
In addition, the efficacy as measured by the mean insulin-like growth factor 1 (IGF-1) and growth hormone (GH) plasma levels is maintained at the same level throughout the
ColoSure is said to be the first clinical test available that looks for a DNA change in the vimentin gene, shown to be important to immunity and other
Mr Howes brings more than 20 years of senior-level pharmaceutical experience to Inotek, most recently serving as president of the Americas Region for Bausch & Lomb where he
The contract was awarded to VGX under the National Institute of Allergy and Infectious Diseases’s HIV Vaccine Design and Development Teams program and brings together HIV vaccine experts
This Phase II trial was set up as a randomized, single-blind, controlled study in 140 healthy volunteers and tested the antibody product in association with Sanofi Pasteur human
According to the company, RGN-457 is based on thymosin beta 4 peptide formulated as an inhaled therapeutic agent to address the cystic fibrosis patient population. JJ Finkelstein, RegeneRx’s
Roche Diagnostics will develop its new product line for RealTime ready qPCR assays with the Universal ProbeLibrary. The financial details of the agreement including commercial milestone payments and
This capital will be utilized to support the ongoing Phase III development program evaluating linaclotide for the treatment of irritable bowel syndrome with constipation and chronic constipation, to
In addition to Smolensk, PPD has added offices in Moscow and St Petersburg, Russia, and Kiev, Ukraine, with this acquisition. Sergey Sudilovsky, currently director general of InnoPharm, will
Mr Junius also has been nominated to join the board, with this nomination to be voted upon at the company’s upcoming annual meeting of shareholders. Mitchel Sayare, currently